Design of nanostructures for versatile therapeutic applications /
Design of Nanostructures for Versatile Therapeutic Applications focuses on antimicrobial, antioxidant and nutraceutical applications of nanostructured materials. Many books discuss these subjects, but not from a pharmaceutical point-of-view. This book covers novel approaches related to the modulatio...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Oxford, United Kingdom :
William Andrew,
[2018]
|
Colección: | Pharmaceutical nanotechnology series
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro; Title page; Table of Contents; Copyright; List of Contributors; Series Preface: Pharmaceutical Nanotechnology; Preface; Chapter 1. Nanotechnology and Parkinson�a#x80;#x99;s disease; Abstract; 1.1 Introduction; 1.2 Genetic and Molecular Mechanisms of Parkinson�a#x80;#x99;s Disease; 1.3 Nanotechnology and Parkinson�a#x80;#x99;s Disease; 1.4 Nanotoxicity; 1.5 Conclusions; References; Further Reading; Chapter 2. Stem cell and gene-based approaches for cardiac repair; Abstract; 2.1 Introduction; 2.2 Natural Repair and Neovascularization in Post-Acute Myocardial Infarction and Their Target Treatment.
- 2.3 Stem Cell Mobilizing Drugs for Cardiac Repair2.4 Current Clinical Treatments in Patients with Acute Myocardial Infarction Remodeling; 2.5 Induced Pluripotent Stem Cells as Cell Therapy for Cardiac Repair; 2.6 Ex Vivo Cell-Based Gene Therapy of Acute Myocardial Infarction in Preclinical Trials; 2.7 Methods for Transplanted Stem Cell Survival Approaches for Cardiac Repair; 2.8 Assessment of Transplanted Cells in the Heart; 2.9 Role of Exosomes in Cell and Gene Therapies for Cardiac Repair; 2.10 Challenges and Future; 2.11 Conclusion; References.
- Chapter 3. Nanostructured lipid carriers: Revolutionizing skin care and topical therapeuticsAbstract; 3.1 Introduction; 3.2 Design and Fabrication of Nanostructured Lipid Carriers; 3.3 Characterization of Nanostructured Lipid Carriers; 3.4 Penetration Profile of Nanostructured Lipid Carriers; 3.5 Stability of Nanostructured Lipid Carriers; 3.6 Benefits of Nanostructured Lipid Carriers in Skin Care and Topical Drug Delivery; 3.7 Nanostructured Lipid Carriers and Consumer Care; 3.8 Regulatory Perspective; 3.9 Summary; References; Further Reading.
- Chapter 4. Nanotechnology for ocular drug deliveryAbstract; 4.1 Introduction; 4.2 Anatomy and Physiology of the Eye; 4.3 Site-Specific Drug Delivery; 4.4 Limitations of Nanopharmaceuticals; 4.5 Conclusion and Future Directions; References; Chapter 5. Polymeric nanoparticles and sponges in the control and stagnation of bleeding and wound healing; Abstract; 5.1 Introduction; 5.2 Overview of Hemostasis; 5.3 Biomaterials; 5.4 Polymeric Nanoparticles; 5.5 Polymeric Sponges: Properties, Compositions, and Application; 5.6 Future Perspectives in Clinical Researches of Sponges.
- 5.7 Impregnation of Nanoparticles in Hemostatic Dressings5.8 Conclusions and Futures Perspectives; Acknowledgments; References; Chapter 6. Nanotechnology approaches to pulmonary drug delivery: Targeted delivery of small molecule and gene-based therapeutics to the lung; Abstract; 6.1 Introduction; 6.2 The Respiratory System; 6.3 Classes of Therapeutics; 6.4 Delivery Vectors; 6.5 Respiratory Diseases; 6.6 Future Developments; References; Chapter 7. Brain targeting with lipidic nanocarriers; Abstract; 7.1 Introduction; 7.2 Lipidic Carriers for Brain Targeting; 7.3 Other Lipidic Nanocarriers.